{"DataElement":{"publicId":"3045435","version":"2","preferredName":"American Joint Committee on Cancer Tumor Stage Code","preferredDefinition":"Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","longName":"AJCC_TUM_STG_CD","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2200363","version":"1","preferredName":"Disease Tumor Stage","preferredDefinition":"Stage of disease based on the primary tumor (T stage).","longName":"DZ_T_STG","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"2192176","version":"1","preferredName":"Diseases and Disorders","preferredDefinition":"A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"Diseases and Disorders","context":"CCR","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E75F33C5-A2DD-7433-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-11-15","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207384","version":"1","preferredName":"Neoplasm Stage","preferredDefinition":"(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C3262:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-221E-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F11E1A98-D46F-67E3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-28","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3040280","version":"2","preferredName":"American Joint Committee on Cancer Pathologic Tumor Stage Code","preferredDefinition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._Caused by or altered by or manifesting disease or pathology._An abnormal tissue growth resulted from uncontrolled cell proliferation.  Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant ones exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia.  Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias. -- 2004 (NCI)_The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body._A system of numbered categories for representation of data.","longName":"AJCC_PATH_TUM_CD","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"15","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"T4c","valueDescription":"T4c Stage Finding","ValueMeaning":{"publicId":"3201440","version":"1","preferredName":"T4c Stage Finding","longName":"3201440","preferredDefinition":"A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T4c TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to a primary tumor that extends to the chest wall, not including the pectoralis muscle, and with edema (including peau d'orange) or ulceration of the skin of the breast or satellite skin nodules confined to the same breast; for ocular adnexal lymphoma it refers to a primary tumor that Involves the maxillofacial, ethmoidal, and/or frontal sinuses; for carcinoma of the conjunctiva it refers to a primary tumor that invades adjacent paranasal sinuses.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T4c TNM Finding","conceptCode":"C48735","definition":"A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T4c TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to a primary tumor that extends to the chest wall, not including the pectoralis muscle, and with edema (including peau d'orange) or ulceration of the skin of the breast or satellite skin nodules confined to the same breast; for ocular adnexal lymphoma it refers to a primary tumor that Involves the maxillofacial, ethmoidal, and/or frontal sinuses; for carcinoma of the conjunctiva it refers to a primary tumor that invades adjacent paranasal sinuses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3E7C-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"513AF040-B11E-0242-E053-F662850A4FFC","beginDate":"2010-04-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"ONEDATA","dateModified":"2017-06-05","deletedIndicator":"No"},{"value":"T4d","valueDescription":"T4d Stage Finding","ValueMeaning":{"publicId":"3201441","version":"1","preferredName":"T4d Stage Finding","longName":"3201441","preferredDefinition":"A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T4d TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to a primary tumor that meets the clinical-pathologic criteria of inflammatory carcinoma; for ocular adnexal lymphoma it refers to a primary tumor with intracranial spread; for carcinoma of the conjunctiva it refers to a primary tumor that invades the brain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T4d TNM Finding","conceptCode":"C48736","definition":"A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T4d TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to a primary tumor that meets the clinical-pathologic criteria of inflammatory carcinoma; for ocular adnexal lymphoma it refers to a primary tumor with intracranial spread; for carcinoma of the conjunctiva it refers to a primary tumor that invades the brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3EA1-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"513AF040-B128-0242-E053-F662850A4FFC","beginDate":"2010-04-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"ONEDATA","dateModified":"2017-06-05","deletedIndicator":"No"},{"value":"Tis","valueDescription":"Tis Stage Finding","ValueMeaning":{"publicId":"3201442","version":"1","preferredName":"Breast Cancer pTis TNM Finding v6 and v7","longName":"3201442v1.00","preferredDefinition":"Breast cancer with a finding of carcinoma in situ. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pTis TNM Finding v6 and v7","conceptCode":"C48974","definition":"Breast cancer with a finding of carcinoma in situ. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3EC4-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"MMADDINENI","dateModified":"2023-06-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"513AF040-B132-0242-E053-F662850A4FFC","beginDate":"2010-03-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"ONEDATA","dateModified":"2017-06-05","deletedIndicator":"No"},{"value":"T3","valueDescription":"T3 Stage Finding","ValueMeaning":{"publicId":"3201433","version":"1","preferredName":"T3 Stage Finding","longName":"3201433","preferredDefinition":"A clinical and/or pathologic primary tumor TNM finding usually indicating that the cancer is locally invasive, without infiltration of adjacent structures.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T3 TNM Finding","conceptCode":"C48728","definition":"A clinical and/or pathologic primary tumor TNM finding usually indicating that the cancer is locally invasive, without infiltration of adjacent structures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3D7B-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"GDEEN","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"513AF040-B13C-0242-E053-F662850A4FFC","beginDate":"2010-04-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"ONEDATA","dateModified":"2017-06-05","deletedIndicator":"No"},{"value":"T3a","valueDescription":"T3a Stage Finding","ValueMeaning":{"publicId":"3201434","version":"1","preferredName":"T3a Stage Finding","longName":"3201434","preferredDefinition":"A general term that refers to a TNM finding of a primary tumor usually indicating that the cancer is locally invasive. The definition of T3a TNM finding depends on the specific type of cancer that it refers to; for example, for kidney cancer it refers to a primary tumor that grossly extends into the renal vein or its segmental (muscle containing) branches or the tumor invades perirenal and/or renal sinus fat but does not extends beyond Gerota's fascia; for cervical cancer it refers to a primary tumor that involves the lower third of vagina, without extension to pelvic wall; for liver cancer it refers to the presence of multiple tumors measuring more than 5 cm in greatest dimension.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T3a TNM Finding","conceptCode":"C48729","definition":"A general term that refers to a TNM finding of a primary tumor usually indicating that the cancer is locally invasive. The definition of T3a TNM finding depends on the specific type of cancer that it refers to; for example, for kidney cancer it refers to a primary tumor that grossly extends into the renal vein or its segmental (muscle containing) branches or the tumor invades perirenal and/or renal sinus fat but does not extends beyond Gerota's fascia; for cervical cancer it refers to a primary tumor that involves the lower third of vagina, without extension to pelvic wall; for liver cancer it refers to the presence of multiple tumors measuring more than 5 cm in greatest dimension.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3DA0-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"GDEEN","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"513AF040-B146-0242-E053-F662850A4FFC","beginDate":"2010-04-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"ONEDATA","dateModified":"2017-06-05","deletedIndicator":"No"},{"value":"T3b","valueDescription":"T3b Stage Finding","ValueMeaning":{"publicId":"3201435","version":"1","preferredName":"T3b Stage Finding","longName":"3201435","preferredDefinition":"A general term that refers to a TNM finding of a primary tumor usually indicating that the cancer is locally invasive. The definition of T3b TNM finding depends on the specific type of cancer that it refers to; for example, for kidney cancer it refers to a primary tumor that grossly extends into the vena cava below the diaphragm; for cervical cancer it refers to a primary tumor that extends to the pelvic wall and/or causes hydronephrosis or nonfunctioning kidney; for liver cancer it refers to a single tumor or multiple tumors of any size involving a major branch of the portal vein or hepatic vein.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T3b TNM Finding","conceptCode":"C48730","definition":"A general term that refers to a TNM finding of a primary tumor usually indicating that the cancer is locally invasive. The definition of T3b TNM finding depends on the specific type of cancer that it refers to; for example, for kidney cancer it refers to a primary tumor that grossly extends into the vena cava below the diaphragm; for cervical cancer it refers to a primary tumor that extends to the pelvic wall and/or causes hydronephrosis or nonfunctioning kidney; for liver cancer it refers to a single tumor or multiple tumors of any size involving a major branch of the portal vein or hepatic vein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3DC5-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"GDEEN","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"513AF040-B150-0242-E053-F662850A4FFC","beginDate":"2010-04-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"ONEDATA","dateModified":"2017-06-05","deletedIndicator":"No"},{"value":"T3c","valueDescription":"T3c Stage Finding","ValueMeaning":{"publicId":"3201436","version":"1","preferredName":"T3c Stage Finding","longName":"3201436","preferredDefinition":"A general term that refers to a TNM finding of a primary tumor usually indicating that the cancer is locally invasive. The definition of T3c TNM finding depends on the specific type of cancer that it refers to; for example, for kidney cancer it refers to a primary tumor that grossly extends into the vena cava above the diaphragm, or invades the wall of the vena cava; for fallopian tube cancer it refers to a primary tumor with peritoneal metastasis outside the pelvis measuring more than 2 cm in diameter; for melanoma of the conjunctiva it refers to a primary tumor invading the orbit.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T3c TNM Finding","conceptCode":"C48731","definition":"A general term that refers to a TNM finding of a primary tumor usually indicating that the cancer is locally invasive. The definition of T3c TNM finding depends on the specific type of cancer that it refers to; for example, for kidney cancer it refers to a primary tumor that grossly extends into the vena cava above the diaphragm, or invades the wall of the vena cava; for fallopian tube cancer it refers to a primary tumor with peritoneal metastasis outside the pelvis measuring more than 2 cm in diameter; for melanoma of the conjunctiva it refers to a primary tumor invading the orbit.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3DEA-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"513AF040-B15A-0242-E053-F662850A4FFC","beginDate":"2010-04-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"ONEDATA","dateModified":"2017-06-05","deletedIndicator":"No"},{"value":"T4","valueDescription":"T4 Stage Finding","ValueMeaning":{"publicId":"3201437","version":"1","preferredName":"T4 Stage Finding","longName":"3201437","preferredDefinition":"A clinical and/or pathologic primary tumor TNM finding indicating direct invasion of adjacent structures by cancer.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T4 TNM Finding","conceptCode":"C48732","definition":"A clinical and/or pathologic primary tumor TNM finding indicating direct invasion of adjacent structures by cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3E0D-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"GDEEN","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"513AF040-B164-0242-E053-F662850A4FFC","beginDate":"2010-04-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"ONEDATA","dateModified":"2017-06-05","deletedIndicator":"No"},{"value":"T4a","valueDescription":"T4a Stage Finding","ValueMeaning":{"publicId":"3201438","version":"1","preferredName":"T4a Stage Finding","longName":"3201438","preferredDefinition":"A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T4a TNM finding depends on the specific type of cancer that it refers to; for example, for bladder cancer it refers to a primary tumor that invades the prostatic stroma, uterus, and vagina; for gastric cancer it refers to a primary tumor that invades the serosa (visceral peritoneum); for colorectal cancer it refers to a primary tumor that penetrates to the surface of the visceral peritoneum.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T4a TNM Finding","conceptCode":"C48733","definition":"A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T4a TNM finding depends on the specific type of cancer that it refers to; for example, for bladder cancer it refers to a primary tumor that invades the prostatic stroma, uterus, and vagina; for gastric cancer it refers to a primary tumor that invades the serosa (visceral peritoneum); for colorectal cancer it refers to a primary tumor that penetrates to the surface of the visceral peritoneum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3E32-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"513AF040-B16E-0242-E053-F662850A4FFC","beginDate":"2010-04-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"ONEDATA","dateModified":"2017-06-05","deletedIndicator":"No"},{"value":"T4b","valueDescription":"T4b Stage Finding","ValueMeaning":{"publicId":"3201439","version":"1","preferredName":"T4b Stage Finding","longName":"3201439","preferredDefinition":"A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T4b TNM finding depends on the specific type of cancer that it refers to; for example, for bladder cancer it refers to a primary tumor that invades the pelvic wall and abdominal wall; for gastric cancer it refers to a primary tumor that invades adjacent structures; for colorectal cancer it refers to a primary tumor with direct invasion or adherence to other organs or structures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T4b TNM Finding","conceptCode":"C48734","definition":"A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T4b TNM finding depends on the specific type of cancer that it refers to; for example, for bladder cancer it refers to a primary tumor that invades the pelvic wall and abdominal wall; for gastric cancer it refers to a primary tumor that invades adjacent structures; for colorectal cancer it refers to a primary tumor with direct invasion or adherence to other organs or structures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3E57-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"513AF040-B178-0242-E053-F662850A4FFC","beginDate":"2010-04-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"ONEDATA","dateModified":"2017-06-05","deletedIndicator":"No"},{"value":"TX","valueDescription":"TX Stage Finding","ValueMeaning":{"publicId":"3201443","version":"1","preferredName":"TX Stage Finding","longName":"3201443","preferredDefinition":"A primary tumor TNM finding indicating that the status of the primary tumor cannot be assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TX TNM Finding","conceptCode":"C48737","definition":"A primary tumor TNM finding indicating that the status of the primary tumor cannot be assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3EE7-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"513AF040-B182-0242-E053-F662850A4FFC","beginDate":"2010-03-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"ONEDATA","dateModified":"2017-06-05","deletedIndicator":"No"},{"value":"T0","valueDescription":"T0 Stage Finding","ValueMeaning":{"publicId":"3201423","version":"1","preferredName":"T0 Stage Finding","longName":"3201423","preferredDefinition":"A primary tumor TNM finding indicating that there is no evidence of primary tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T0 TNM Finding","conceptCode":"C48719","definition":"A primary tumor TNM finding indicating that there is no evidence of primary tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3C0F-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"ONEDATA","dateModified":"2011-03-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"513AF040-B18C-0242-E053-F662850A4FFC","beginDate":"2010-03-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"ONEDATA","dateModified":"2017-06-05","deletedIndicator":"No"},{"value":"T1","valueDescription":"T1 Stage Finding","ValueMeaning":{"publicId":"3201424","version":"1","preferredName":"T1 Stage Finding","longName":"3201424","preferredDefinition":"A clinical and/or pathologic primary tumor TNM finding indicating that the cancer is limited to the site of growth.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T1 TNM Finding","conceptCode":"C48720","definition":"A clinical and/or pathologic primary tumor TNM finding indicating that the cancer is limited to the site of growth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3C32-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"513AF040-B196-0242-E053-F662850A4FFC","beginDate":"2010-03-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"ONEDATA","dateModified":"2017-06-05","deletedIndicator":"No"},{"value":"T1a","valueDescription":"T1a Stage Finding","ValueMeaning":{"publicId":"3201425","version":"1","preferredName":"T1a Stage Finding","longName":"3201425","preferredDefinition":"A general term that refers to a TNM finding of a primary tumor limited to the site of growth.  The definition of T1a TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to a primary tumor that is more than 0.1cm, but not more than 0.5 cm in greatest dimension; for kidney cancer it refers to a primary tumor that is 4 cm or less in greatest dimension; and for thyroid cancer it refers to a primary tumor that is 1 cm or less in greatest dimension.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T1a TNM Finding","conceptCode":"C48721","definition":"A general term that refers to a TNM finding of a primary tumor limited to the site of growth.  The definition of T1a TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to a primary tumor that is more than 0.1cm, but not more than 0.5 cm in greatest dimension; for kidney cancer it refers to a primary tumor that is 4 cm or less in greatest dimension; and for thyroid cancer it refers to a primary tumor that is 1 cm or less in greatest dimension.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3C57-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"513AF040-B1A0-0242-E053-F662850A4FFC","beginDate":"2010-03-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"ONEDATA","dateModified":"2017-06-05","deletedIndicator":"No"},{"value":"T1b","valueDescription":"T1b Stage Finding","ValueMeaning":{"publicId":"3201426","version":"1","preferredName":"T1b Stage Finding","longName":"3201426","preferredDefinition":"A general term that refers to a TNM finding of a primary tumor limited to the site of growth.  The definition of T1b TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to a primary tumor that is more than 0.5 cm, but not more than 1.0 cm in greatest dimension; for kidney cancer it refers to a primary tumor that is more than 4 cm, but not more than 7 cm in greatest dimension; and for thyroid cancer it refers to a primary tumor that is more than 1 cm but not more than 2 cm in greatest dimension.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T1b TNM Finding","conceptCode":"C48722","definition":"A general term that refers to a TNM finding of a primary tumor limited to the site of growth.  The definition of T1b TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to a primary tumor that is more than 0.5 cm, but not more than 1.0 cm in greatest dimension; for kidney cancer it refers to a primary tumor that is more than 4 cm, but not more than 7 cm in greatest dimension; and for thyroid cancer it refers to a primary tumor that is more than 1 cm but not more than 2 cm in greatest dimension.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3C7C-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"513AF040-B1AA-0242-E053-F662850A4FFC","beginDate":"2010-03-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"ONEDATA","dateModified":"2017-06-05","deletedIndicator":"No"},{"value":"T1c","valueDescription":"T1c Stage Finding","ValueMeaning":{"publicId":"3201427","version":"1","preferredName":"T1c Stage Finding","longName":"3201427","preferredDefinition":"A general term that refers to a TNM finding of a primary tumor limited to the site of growth.  The definition of T1c TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to a primary tumor that is more than 1.0 cm, but not more than 2.0 cm in greatest dimension; for uterine corpus cancer it refers to a primary tumor that invades one-half or more of the myometrium; and for melanoma of the iris it refers to a primary tumor limited to the iris with secondary glaucoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T1c TNM Finding","conceptCode":"C48723","definition":"A general term that refers to a TNM finding of a primary tumor limited to the site of growth.  The definition of T1c TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to a primary tumor that is more than 1.0 cm, but not more than 2.0 cm in greatest dimension; for uterine corpus cancer it refers to a primary tumor that invades one-half or more of the myometrium; and for melanoma of the iris it refers to a primary tumor limited to the iris with secondary glaucoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3CA1-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"GDEEN","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"513AF040-B1B4-0242-E053-F662850A4FFC","beginDate":"2010-03-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"ONEDATA","dateModified":"2017-06-05","deletedIndicator":"No"},{"value":"T1mi","valueDescription":"T1mi Stage Finding","ValueMeaning":{"publicId":"3201428","version":"1","preferredName":"T1mi Stage Finding","longName":"3201428","preferredDefinition":"A term that refers to a TNM finding of a primary tumor limited to the site of growth and indicates microinvasion only.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T1mi TNM Finding","conceptCode":"C95805","definition":"A term that refers to a TNM finding of a primary tumor limited to the site of growth and indicates microinvasion only.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3CC6-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"513AF040-B1BE-0242-E053-F662850A4FFC","beginDate":"2010-03-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"ONEDATA","dateModified":"2017-06-05","deletedIndicator":"No"},{"value":"T2","valueDescription":"T2 Stage Finding","ValueMeaning":{"publicId":"3201429","version":"1","preferredName":"T2 Stage Finding","longName":"3201429","preferredDefinition":"A general term that refers to a TNM finding of primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to primary tumor that is more than 2.0 cm, but not more than 5.0 cm in greatest dimension; for cutaneous melanoma it refers to primary tumor that is 1.01 to 2 mm in thickness, with or without ulceration; for colorectal cancer it refers to primary tumor with invasion into the muscularis propria; and for bladder cancer it refers to primary tumor with invasion into the muscle layer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T2 TNM Finding","conceptCode":"C48724","definition":"A general term that refers to a TNM finding of primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to primary tumor that is more than 2.0 cm, but not more than 5.0 cm in greatest dimension; for cutaneous melanoma it refers to primary tumor that is 1.01 to 2 mm in thickness, with or without ulceration; for colorectal cancer it refers to primary tumor with invasion into the muscularis propria; and for bladder cancer it refers to primary tumor with invasion into the muscle layer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3CE9-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"513AF040-B1C8-0242-E053-F662850A4FFC","beginDate":"2010-04-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"ONEDATA","dateModified":"2017-06-05","deletedIndicator":"No"},{"value":"T2a","valueDescription":"T2a Stage Finding","ValueMeaning":{"publicId":"3201430","version":"1","preferredName":"T2a Stage Finding","longName":"3201430","preferredDefinition":"A general term that refers to a TNM finding of a primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2a TNM finding depends on the specific type of cancer that it refers to; for example, for kidney cancer it refers to a primary tumor that measures more than 7 cm but less than or equal to 10 cm in greatest dimension, and is limited to the kidney; for bladder cancer it refers to a primary tumor that invades the superficial muscularis propria (inner half); for cervical cancer it refers to a primary tumor that invades beyond the uterus but not to the pelvic wall or to the lower third of vagina and there is no parametrial invasion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T2a TNM Finding","conceptCode":"C48725","definition":"A general term that refers to a TNM finding of a primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2a TNM finding depends on the specific type of cancer that it refers to; for example, for kidney cancer it refers to a primary tumor that measures more than 7 cm but less than or equal to 10 cm in greatest dimension, and is limited to the kidney; for bladder cancer it refers to a primary tumor that invades the superficial muscularis propria (inner half); for cervical cancer it refers to a primary tumor that invades beyond the uterus but not to the pelvic wall or to the lower third of vagina and there is no parametrial invasion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3D0E-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"GDEEN","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"513AF040-B1D2-0242-E053-F662850A4FFC","beginDate":"2010-04-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"ONEDATA","dateModified":"2017-06-05","deletedIndicator":"No"},{"value":"T2b","valueDescription":"T2b Stage Finding","ValueMeaning":{"publicId":"3201431","version":"1","preferredName":"T2b Stage Finding","longName":"3201431","preferredDefinition":"A general term that refers to a TNM finding of a primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2b TNM finding depends on the specific type of cancer that it refers to; for example, for kidney cancer it refers to a primary tumor that measures more than 10 cm in greatest dimension, and  is limited to the kidney; for bladder cancer it refers to a primary tumor that invades the deep muscularis propria (outer half); for cervical cancer it refers to a primary tumor that invades beyond the uterus but not to the pelvic wall or to the lower third of vagina and there is parametrial invasion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T2b TNM Finding","conceptCode":"C48726","definition":"A general term that refers to a TNM finding of a primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2b TNM finding depends on the specific type of cancer that it refers to; for example, for kidney cancer it refers to a primary tumor that measures more than 10 cm in greatest dimension, and is limited to the kidney; for bladder cancer it refers to a primary tumor that invades the deep muscularis propria (outer half); for cervical cancer it refers to a primary tumor that invades beyond the uterus but not to the pelvic wall or to the lower third of vagina and there is parametrial invasion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3D33-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"GDEEN","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"513AF040-B1DC-0242-E053-F662850A4FFC","beginDate":"2010-04-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"ONEDATA","dateModified":"2017-06-05","deletedIndicator":"No"},{"value":"T2c","valueDescription":"T2c Stage Finding","ValueMeaning":{"publicId":"3201432","version":"1","preferredName":"T2c Stage Finding","longName":"3201432","preferredDefinition":"A general term that refers to a TNM finding of a primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2c TNM finding depends on the specific type of cancer that it refers to; for example, for prostate cancer it refers to a primary tumor that involves both lobes of the prostate gland; for ovarian cancer it refers to a primary tumor that involves one or both ovaries with extension or implants on the uterus and/or fallopian tubes, or other pelvic tissues, with malignant cells in either ascites or peritoneal washings; for fallopian tube cancer it refers to a primary tumor with pelvic extension and malignant cells in ascites or peritoneal washings.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T2c TNM Finding","conceptCode":"C48727","definition":"A general term that refers to a TNM finding of a primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2c TNM finding depends on the specific type of cancer that it refers to; for example, for prostate cancer it refers to a primary tumor that involves both lobes of the prostate gland; for ovarian cancer it refers to a primary tumor that involves one or both ovaries with extension or implants on the uterus and/or fallopian tubes, or other pelvic tissues, with malignant cells in either ascites or peritoneal washings; for fallopian tube cancer it refers to a primary tumor with pelvic extension and malignant cells in ascites or peritoneal washings.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3D58-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"GDEEN","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"513AF040-B1E6-0242-E053-F662850A4FFC","beginDate":"2010-04-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"ONEDATA","dateModified":"2017-06-05","deletedIndicator":"No"},{"value":"Ta","valueDescription":"Ta Stage Finding","ValueMeaning":{"publicId":"3205588","version":"1","preferredName":"Ta Stage Finding","longName":"3205588","preferredDefinition":"A term that refers to a TNM finding of a primary, non-invasive, papillary cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pTa TNM Finding","conceptCode":"C96025","definition":"A term that refers to a TNM finding of a primary, non-invasive, papillary cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9EC6B910-A661-E8D4-E040-BB89AD43022D","latestVersionIndicator":"Yes","beginDate":"2011-03-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"513AF040-B1F0-0242-E053-F662850A4FFC","beginDate":"2011-03-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"ONEDATA","dateModified":"2017-06-05","deletedIndicator":"No"},{"value":"Tis (LCIS)","valueDescription":"Tis Stage Finding Lobular Breast Carcinoma In Situ","ValueMeaning":{"publicId":"3201555","version":"1","preferredName":"Tis Stage Finding Lobular Breast Carcinoma In Situ","longName":"3201555","preferredDefinition":"A term that refers to a TNM finding of a primary tumor microscopically defined as carcinoma in situ.: A non-invasive adenocarcinoma of the breast characterized by a proliferation of monomorphic cells completely filling the lumina.  The overall lobular architecture is preserved.  It is frequently multifocal (90% in some series) and bilateral.  It seldom becomes invasive; however there is an increased risk of infiltrating ductal adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pTis TNM Finding","conceptCode":"C48738","definition":"A term that refers to a TNM finding of a primary tumor microscopically defined as carcinoma in situ.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Breast Lobular Carcinoma In Situ","conceptCode":"C4018","definition":"A non-invasive adenocarcinoma of the breast characterized by a proliferation of monomorphic cells completely filling the lumina.  The overall lobular architecture is preserved.  It is frequently multifocal (90% in some series) and bilateral.  It seldom becomes invasive; however there is an increased risk of infiltrating ductal adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E24E347-9D40-3835-E040-BB89AD4379CD","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"513AF040-B1FA-0242-E053-F662850A4FFC","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"ONEDATA","dateModified":"2017-06-05","deletedIndicator":"No"},{"value":"Tis (Paget's)","valueDescription":"Tis Stage Finding Paget Disease of the Breast without Invasive Carcinoma","ValueMeaning":{"publicId":"3201556","version":"1","preferredName":"Tis Stage Finding Paget Disease of the Breast without Invasive Carcinoma","longName":"3201556","preferredDefinition":"A term that refers to a TNM finding of a primary tumor microscopically defined as carcinoma in situ.: Paget disease involving the skin overlying the mammary gland, without accompanying invasive ductal or lobular breast carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pTis TNM Finding","conceptCode":"C48738","definition":"A term that refers to a TNM finding of a primary tumor microscopically defined as carcinoma in situ.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Breast Paget Disease without Invasive Carcinoma","conceptCode":"C47858","definition":"Paget disease involving the skin overlying the mammary gland, without accompanying invasive ductal or lobular breast carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E24E347-9D66-3835-E040-BB89AD4379CD","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"513AF040-B204-0242-E053-F662850A4FFC","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"ONEDATA","dateModified":"2017-06-05","deletedIndicator":"No"},{"value":"Tis (DCIS)","valueDescription":"Tis Stage Finding Ductal Breast Carcinoma In Situ","ValueMeaning":{"publicId":"3201554","version":"1","preferredName":"Tis Stage Finding Ductal Breast Carcinoma In Situ","longName":"3201554","preferredDefinition":"A term that refers to a TNM finding of a primary tumor microscopically defined as carcinoma in situ.: A carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pTis TNM Finding","conceptCode":"C48738","definition":"A term that refers to a TNM finding of a primary tumor microscopically defined as carcinoma in situ.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Breast Ductal Carcinoma In Situ","conceptCode":"C2924","definition":"A breast carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E24E347-9D1A-3835-E040-BB89AD4379CD","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"ONEDATA","dateModified":"2011-03-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"513AF040-B20E-0242-E053-F662850A4FFC","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"ONEDATA","dateModified":"2017-06-05","deletedIndicator":"No"},{"value":"T2a2","valueDescription":"Stage T2a2 Finding","ValueMeaning":{"publicId":"3151385","version":"1","preferredName":"Stage T2a2 Finding","longName":"3151385","preferredDefinition":"Cervical cancer invades beyond uterus but not to pelvic wall or to lower third of vagina.  There is no parametrial invasion.  Clinically visible lesions more than 4.0 cm in greatest dimension are present.  (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cervical Cancer pT2a2 TNM Finding v7","conceptCode":"C89538","definition":"Cervical cancer invades beyond uterus but not to pelvic wall or to lower third of vagina.  There is no parametrial invasion.  Clinically visible lesions more than 4.0 cm in greatest dimension are present.  (from AJCC 7th Ed.)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9299B94C-431A-BA08-E040-BB89AD430CAF","latestVersionIndicator":"Yes","beginDate":"2010-10-14","endDate":null,"createdBy":"WHITES","dateCreated":"2010-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"513AF040-B218-0242-E053-F662850A4FFC","beginDate":"2011-08-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"ONEDATA","dateModified":"2017-06-05","deletedIndicator":"No"},{"value":"T2a1","valueDescription":"Stage T2a1 Finding","ValueMeaning":{"publicId":"3151383","version":"1","preferredName":"Stage T2a1 Finding","longName":"3151383","preferredDefinition":"Cervical cancer invades beyond uterus but not to pelvic wall or to lower third of vagina.  There is no parametrial invasion.  Clinically visible lesions 4.0 cm or less in greatest dimension are present.  (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cervical Cancer pT2a1 TNM Finding v7","conceptCode":"C89537","definition":"Cervical cancer invades beyond uterus but not to pelvic wall or to lower third of vagina.  There is no parametrial invasion.  Clinically visible lesions 4.0 cm or less in greatest dimension are present.  (from AJCC 7th Ed.)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9299B94C-42F4-BA08-E040-BB89AD430CAF","latestVersionIndicator":"Yes","beginDate":"2010-10-14","endDate":null,"createdBy":"WHITES","dateCreated":"2010-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"513AF040-B222-0242-E053-F662850A4FFC","beginDate":"2011-08-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"ONEDATA","dateModified":"2017-06-05","deletedIndicator":"No"},{"value":"T1a2","valueDescription":"Stage T1a2 Finding","ValueMeaning":{"publicId":"3151371","version":"1","preferredName":"Stage T1a2 Finding","longName":"3151371","preferredDefinition":"Invasive cervical cancer with measured stromal invasion more than 3.0 mm and not more than 5.0 mm with a horizontal spread 7.0 mm or less. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cervical Cancer pT1a2 TNM Finding v7","conceptCode":"C89529","definition":"Invasive cervical cancer with measured stromal invasion more than 3.0 mm and not more than 5.0 mm with a horizontal spread 7.0 mm or less. (from AJCC 7th Ed.)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9299B94C-4210-BA08-E040-BB89AD430CAF","latestVersionIndicator":"Yes","beginDate":"2010-10-14","endDate":null,"createdBy":"WHITES","dateCreated":"2010-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"513AF040-B22C-0242-E053-F662850A4FFC","beginDate":"2011-08-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"ONEDATA","dateModified":"2017-06-05","deletedIndicator":"No"},{"value":"T1a1","valueDescription":"Stage T1a1 Finding","ValueMeaning":{"publicId":"3151369","version":"1","preferredName":"Stage T1a1 Finding","longName":"3151369","preferredDefinition":"A pathologic primary tumor TNM stage finding.  The definition of pT1a stage finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT1a stage finding is defined as follows: cancer with tumor size more than 0.1 cm, but not more than 0.5 cm in greatest dimension; for lung cancer, pT1a stage finding is defined as follows: cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pT1a TNM Finding","conceptCode":"C48760","definition":"A pathologic primary tumor TNM finding.  The definition of pT1a finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT1a finding is defined as follows: cancer with tumor size more than 0.1 cm, but not more than 0.5 cm in greatest dimension; for lung cancer, pT1a finding is defined as follows: cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9299B94C-41EA-BA08-E040-BB89AD430CAF","latestVersionIndicator":"Yes","beginDate":"2010-10-14","endDate":null,"createdBy":"WHITES","dateCreated":"2010-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"513AF040-B236-0242-E053-F662850A4FFC","beginDate":"2011-08-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"ONEDATA","dateModified":"2017-06-05","deletedIndicator":"No"},{"value":"T1b2","valueDescription":"T1b2 Stage Finding","ValueMeaning":{"publicId":"3151377","version":"1","preferredName":"T1b2 Stage Finding","longName":"3151377","preferredDefinition":"Invasive cervical cancer with clinically visible lesion more than 4.0 cm in greatest dimension confined to the cervix. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cervical Cancer pT1b2 TNM Finding v7","conceptCode":"C89534","definition":"Invasive cervical cancer with clinically visible lesion more than 4.0 cm in greatest dimension confined to the cervix. (from AJCC 7th Ed.)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9299B94C-4282-BA08-E040-BB89AD430CAF","latestVersionIndicator":"Yes","beginDate":"2010-10-14","endDate":null,"createdBy":"WHITES","dateCreated":"2010-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"513AF040-B240-0242-E053-F662850A4FFC","beginDate":"2012-01-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"ONEDATA","dateModified":"2017-06-05","deletedIndicator":"No"},{"value":"T1b1","valueDescription":"T1b1 Stage Finding","ValueMeaning":{"publicId":"3151375","version":"1","preferredName":"T1b1 Stage Finding","longName":"3151375","preferredDefinition":"Cervical cancer with clinically visible lesion 4.0 cm or less in greatest dimension confined to the cervix. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cervical Cancer pT1b1 TNM Finding v7","conceptCode":"C89533","definition":"Cervical cancer with clinically visible lesion 4.0 cm or less in greatest dimension confined to the cervix. (from AJCC 7th Ed.)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9299B94C-425C-BA08-E040-BB89AD430CAF","latestVersionIndicator":"Yes","beginDate":"2010-10-14","endDate":null,"createdBy":"WHITES","dateCreated":"2010-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"513AF040-B24A-0242-E053-F662850A4FFC","beginDate":"2012-01-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"ONEDATA","dateModified":"2017-06-05","deletedIndicator":"No"},{"value":"T4e","valueDescription":"T4e Stage Finding","ValueMeaning":{"publicId":"4500232","version":"1","preferredName":"T4e Stage Finding","longName":"4500232","preferredDefinition":"Any tumor size category with extraocular extension more than 5 mm in diameter. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Melanoma of the Ciliary Body and Choroid pT4e TNM Finding v7","conceptCode":"C88706","definition":"Any tumor size category with extraocular extension more than 5 mm in diameter. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0461CA29-8CDD-9EFC-E050-BB89AD434CBC","latestVersionIndicator":"Yes","beginDate":"2014-10-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-10-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"513AF040-B254-0242-E053-F662850A4FFC","beginDate":"2014-10-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"ONEDATA","dateModified":"2017-06-05","deletedIndicator":"No"},{"value":"T3d","valueDescription":"T3d Stage Finding","ValueMeaning":{"publicId":"4500233","version":"1","preferredName":"T3d Stage Finding","longName":"4500233","preferredDefinition":"Tumor size category 3 with ciliary body involvement and extraocular extension less than or equal to 5 mm in diameter. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Melanoma of the Ciliary Body and Choroid pT3d TNM Finding v7","conceptCode":"C88700","definition":"Tumor size category 3 with ciliary body involvement and extraocular extension less than or equal to 5 mm in diameter. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0461CA29-8D02-9EFC-E050-BB89AD434CBC","latestVersionIndicator":"Yes","beginDate":"2014-10-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-10-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"513AF040-B25E-0242-E053-F662850A4FFC","beginDate":"2014-10-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"ONEDATA","dateModified":"2017-06-05","deletedIndicator":"No"},{"value":"T2d","valueDescription":"T2d Stage Finding","ValueMeaning":{"publicId":"4500234","version":"1","preferredName":"T2d Stage Finding","longName":"4500234","preferredDefinition":"Tumor size category 2 with ciliary body involvement and extraocular extension less than or equal to 5 mm in diameter. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Melanoma of the Ciliary Body and Choroid pT2d TNM Finding v7","conceptCode":"C88695","definition":"Tumor size category 2 with ciliary body involvement and extraocular extension less than or equal to 5 mm in diameter. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0461CA29-8D27-9EFC-E050-BB89AD434CBC","latestVersionIndicator":"Yes","beginDate":"2014-10-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-10-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"513AF040-B268-0242-E053-F662850A4FFC","beginDate":"2014-10-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"ONEDATA","dateModified":"2017-06-05","deletedIndicator":"No"},{"value":"T5","valueDescription":"T5 Stage Finding","ValueMeaning":{"publicId":"5608187","version":"1","preferredName":"T5 Stage Finding","longName":"5608187","preferredDefinition":"An antiquated primary tumor finding term that refers to colorectal cancer which has spread by direct extension beyond the immediately adjacent organs or tissues. (AJCC 1st Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T5 TNM Finding","conceptCode":"C132010","definition":"An antiquated primary tumor finding term that refers to colorectal cancer which has spread by direct extension beyond the immediately adjacent organs or tissues. (AJCC 1st Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"440A362C-966D-495A-E053-F662850AF934","latestVersionIndicator":"Yes","beginDate":"2016-12-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"513AF040-B272-0242-E053-F662850A4FFC","beginDate":"2016-12-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"ONEDATA","dateModified":"2017-06-05","deletedIndicator":"No"},{"value":"Tis (AIS)","valueDescription":"Tis (AIS)","ValueMeaning":{"publicId":"6078410","version":"1","preferredName":"Tis (AIS)","longName":"6078410","preferredDefinition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.: Lung cancer with a finding of carcinoma in situ. Squamous cell carcinoma in situ (SCIS). Adenocarcinoma in situ (AIS): adenocarcinoma with pure lepidic pattern, 3 cm or less in greatest dimension. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lung Cancer pTis TNM Finding v8","conceptCode":"C136447","definition":"Lung cancer with a finding of carcinoma in situ. Squamous cell carcinoma in situ (SCIS). Adenocarcinoma in situ (AIS): adenocarcinoma with pure lepidic pattern, 3 cm or less in greatest dimension. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65D4FD4C-77C9-2C2A-E053-F662850AFB25","latestVersionIndicator":"Yes","beginDate":"2018-02-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-22","modifiedBy":"COOPERM","dateModified":"2018-02-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"65D4FD4C-77E2-2C2A-E053-F662850AFB25","beginDate":"2018-02-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-22","modifiedBy":"ONEDATA","dateModified":"2018-02-22","deletedIndicator":"No"},{"value":"Tis (SCIS)","valueDescription":"Tis (SCIS)","ValueMeaning":{"publicId":"6078411","version":"1","preferredName":"Tis (SCIS)","longName":"6078411","preferredDefinition":"A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.: In the natural or normal place, confined to the site of origin without invasion of neighboring tissues.: Lung cancer with a finding of carcinoma in situ. Squamous cell carcinoma in situ (SCIS). Adenocarcinoma in situ (AIS): adenocarcinoma with pure lepidic pattern, 3 cm or less in greatest dimension. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Squamous Cell Carcinoma","conceptCode":"C2929","definition":"A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"In Situ","conceptCode":"C14160","definition":"In the natural or normal place, confined to the site of origin without invasion of neighboring tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lung Cancer pTis TNM Finding v8","conceptCode":"C136447","definition":"Lung cancer with a finding of carcinoma in situ. Squamous cell carcinoma in situ (SCIS). Adenocarcinoma in situ (AIS): adenocarcinoma with pure lepidic pattern, 3 cm or less in greatest dimension. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65D4FD4C-77EC-2C2A-E053-F662850AFB25","latestVersionIndicator":"Yes","beginDate":"2018-02-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-22","modifiedBy":"COOPERM","dateModified":"2018-02-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"65D4FD4C-7805-2C2A-E053-F662850AFB25","beginDate":"2018-02-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-22","modifiedBy":"ONEDATA","dateModified":"2018-02-22","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3040383","version":"1","preferredName":"American Joint Committee on Cancer Pathologic Neoplasm Stage Code","preferredDefinition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:Pathologic; caused by or altered by or manifesting disease or pathology.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.:A system of numbered categories for representation of data.","longName":"C39315:C25610:C3262:C16899:C25","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"832E922F-7431-5B88-E040-BB89AD435D60","latestVersionIndicator":"Yes","beginDate":"2010-04-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-01","modifiedBy":"ONEDATA","dateModified":"2010-04-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"513AF040-B108-0242-E053-F662850A4FFC","latestVersionIndicator":"Yes","beginDate":"2017-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"COOPERM","dateModified":"2018-02-22","changeDescription":"6/5/17 Versioned to correct error in data type and max length. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2813054","version":"1","longName":"St. Joseph Hospital","context":"NCIP"},{"publicId":"2813056","version":"1","longName":"St. Joseph New CDEs","context":"NCIP"}]},{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]},{"publicId":"3787498","version":"1","longName":"TCGA 2.6 by Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3787505","version":"1","longName":"HNSC","context":"NCIP"},{"publicId":"3787508","version":"1","longName":"KIRP","context":"NCIP"},{"publicId":"3787513","version":"1","longName":"LUSC","context":"NCIP"},{"publicId":"3787514","version":"1","longName":"OV","context":"NCIP"},{"publicId":"3787516","version":"1","longName":"PRAD","context":"NCIP"},{"publicId":"3787502","version":"1","longName":"CESC","context":"NCIP"},{"publicId":"3787503","version":"1","longName":"COAD","context":"NCIP"},{"publicId":"3787506","version":"1","longName":"KICH","context":"NCIP"},{"publicId":"3787507","version":"1","longName":"KIRC","context":"NCIP"},{"publicId":"3787499","version":"1","longName":"BLCA","context":"NCIP"},{"publicId":"3787500","version":"1","longName":"BRCA","context":"NCIP"},{"publicId":"3787511","version":"1","longName":"LIHC","context":"NCIP"},{"publicId":"3787519","version":"1","longName":"SKCM","context":"NCIP"},{"publicId":"3787512","version":"1","longName":"LUAD","context":"NCIP"},{"publicId":"3787517","version":"1","longName":"READ","context":"NCIP"},{"publicId":"3787520","version":"1","longName":"STAD","context":"NCIP"},{"publicId":"3787522","version":"1","longName":"UCEC","context":"NCIP"},{"publicId":"3787521","version":"1","longName":"THCA","context":"NCIP"},{"publicId":"3787515","version":"1","longName":"PAAD","context":"NCIP"}]},{"publicId":"5242953","version":"1","longName":"BCAN: Bladder Cancer Advocacy Network","context":"NCIP","ClassificationSchemeItems":[{"publicId":"5242975","version":"1","longName":"UC-GENOME","context":"NCIP"}]},{"publicId":"5589063","version":"1","longName":"CDDP/CTSP (Cancer Driver Discovery Program/Clinical Trial Sequencing Project)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"5589068","version":"1","longName":"CDDP/CTSP","context":"NCIP"}]}],"AlternateNames":[{"name":"AJCC_tumor_stage_code","type":"HCMI Name","context":"OCG"},{"name":"OCG","type":"USED_BY","context":"OCG"},{"name":"pathologic_T","type":"TCGA_XML_Name","context":"NCIP"},{"name":"AJCC_TUM_STG_CD","type":"USED_BY","context":"DCP"}],"ReferenceDocuments":[{"name":"Pathologic Spread: Primary Tu","type":"Preferred Question Text","description":"Pathologic Spread: Primary Tumor (pT)","url":null,"context":"NCIP"},{"name":"TCGA Question Text","type":"Alternate Question Text","description":"Primary Tumor (T) Category at Initial Diagnosis","url":null,"context":"NCIP"},{"name":"Pathologic T Stage","type":"Alternate Question Text","description":"Pathologic T Stage","url":null,"context":"DCP"},{"name":"TCGA Other Malignancy Question","type":"Application Standard Question Text","description":"Pathologic Spread: Primary Tumor (pT) for the Other Malignancy","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"513B65D5-31BD-788B-E053-F662850A263B","latestVersionIndicator":"Yes","beginDate":"2017-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"FORMBUILDER","dateModified":"2019-02-21","changeDescription":"Curated to support St. Joseph Orange Pathology trial.  This CDE is intended to be used for all disease types, which is the reason the Permissible values reference generic AJCC criteria. Modified Origin to remove specific reference to AJCC 7th Edition. 3/8/11 mc Versioned to correct error in data type and max length. 6/5/17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}